Hip | Knee Joint Preservation Specialist Singapore 

Engineering the Alternative

In the current medical landscape, "Joint Preservation" is often used as a marketing label for simple injections. In our practice, preservation is a clinical discipline. It is the application of the Tier 1 (Molecular) and Tier 2 (Structural) protocols of the Conservation Arthroplasty framework.

If a joint can be molded biologically or structurally to restore function, then a mechanical replacement is a failure of logic. Preservation is not about "waiting"; it is about active intervention based on your present state of being.

Tier 1: Molecular Integrity (The Biological Entry Point)

For patients with early-stage wear or persistent inflammation where the joint structure is still intact, we address the biology before the mechanics.

• The Molecular Standard: Utilizing Dr. Nathan’s role as the original consultant for the technical implementation of APS (nStride) in Singapore, we use molecular signaling to quiet the joint environment.

• Zero-Substitution: We do not misrepresent PRP as a "stem cell alternative." If your joint state requires molecular signaling, we provide the specific solution we helped bring to market.

Tier 2: Structural Saving & The Truth About Stem Cells

We utilize Stem Cells only where they are clinically effective: for isolated structural defects and Avascular Necrosis (AVN).

The Clinical Reality of Stem Cells

Contrary to common marketing claims, there is no evidence that stem cell therapy works for generalized Osteoarthritis. Injectable preparations into arthritic knees are often little more than a placebo effect because they cannot address the 5 hallmarks of the arthritic joint:

1. Osteophytes (Bone spurs)

2. Subchondral Sclerosis (Hardened bone)

3. Cysts (Weakened bone integrity)

4. Malalignment (Varus/Valgus distortion)

5. Loss of Joint Space

Stem cells only attempt to address the fifth factor. Without addressing the other four, the treatment is fundamentally incomplete.

When We Use Stem Cells (The Tier 2 State)

We apply stem cell therapy only when a patient presents with an isolated cartilage defect (typically from trauma) or bone death (AVN).

• The Technique: We utilize refined Microfracture techniques combined with Membranes (such as Hyalofast) to trap and concentrate stem cells at the site of the defect.

• The Goal: This is a "stop-gap" measure designed to reconstitute cartilage integrity for active patients and athletes, allowing a return to high-level function without or before considering Arthroplasty.

Provenance: A Decade of Research

Our use of cellular therapy is grounded in primary research, not industry trends.

• 2003: Dr. Nathan published one of the earliest stem cell papers in Singapore (Tissue Engineering, 2003), demonstrating the ability of adipose-derived cells to reconstitute cartilage defects.

• 2014: We established the documented clinical portal for AVN Stem Cell protocols, focusing on structural bone-saving rather than simple "replacement."